zanamivir

Poland

Drugs containing this active substance

  • RELENZA

    The medicine is used for the treatment of influenza (reduces the severity of symptoms and accelerates recovery) and for the prevention of influenza during an epidemic.

    Form: powder for inhalation, divided

    Active substance Dosage
    zanamivir 5 mg

    ATC: J05AH01

    Manufacturer: Glaxo Wellcome Production GlaxoSmithKline Trading Services Limited